Zebrafish research identifies treatment target for eye muscle repair

Lab study may power new treatment to correct crossed eyes

Author | Shantell M. Kirkendoll

By learning how zebrafish regenerate their eye muscles, researchers could help figure out how to help humans do the same.

University of Michigan Kellogg Eye Center researchers have published findings in PLOS One on the role of insulin-like growth factor (IGF) in promoting extraocular muscle repair and regeneration in zebrafish.

If the process can be replicated in humans it stands to power new treatments for vision loss caused by strabismus, known as crossed eyes, and congenital ptosis, both common childhood eye diseases characterized by poorly developed eye muscles. 

Zebrafish have the unique ability to grow back damaged hearts or when they are blinded, regain the ability to see. They have become unlikely heroes in research labs around the world.

Because zebrafish share 70 percent of humans’ genetic code, it’s often possible to use them to study human genetic traits and diseases. They are assisting Kellogg researchers in basic science to regenerate the eye.

Alon Kahana, M.D., Ph.D., an oculoplastic surgeon at U-M Kellogg Eye Center, studies the molecular mechanisms of eye muscle regeneration and the signals that regulate the regeneration process. 

For the lab study, Kahana and colleagues created a model of eye muscle dysfunction in zebrafish to study strabismus as well as congenital ptosis, the term used for droopy eyelids in children.

With strabismus, eyeglasses, exercises, or patching can help straighten the eyes and restore binocular vision, but surgery is often needed to save vision and restore function, Kahana says.

“Although humans don’t have this ability to regenerate extraocular muscle, there may be a way to enhance eye muscle repair before, during or after surgery – or maybe even to replace surgery in some cases,” says senior study author Kahana. “IGF-1 is a hormone that activates critical signaling pathways in both humans and zebrafish, and similar biology may one day provide a path toward translating our findings to clinical care.”

Kellogg authors make the case for IGF signaling as a key regulator of extraocular muscle re-growth and timing.

IGF signaling is critical for reprogramming muscle cells in the late stages of extraocular muscle regeneration, according to the study, and in the lab blocking IGF signaling diminished muscle fiber growth.

“Our fish are transparent, and the injured muscle is marked with fluorescent protein. So we can visualize the muscle repairing and growing,” says Kahana, a member of the A. Alfred Taubman Medical Research Institute. “Also because it lives in water, we can add drugs to the water to block or enhance muscle and nerve response to injury.”

The next research step is to examine the activities of the signaling pathway, and learn if the role of IGF is shared in the same reparative pathways for other muscle tissue types. 

Additional authors: Lead author Alfonso Saera-Vila; Ke’ale W. Louie; Cuilee Sha; Ryan M. Kelly and Phillip E. Kish, all of the University of Michigan.

Citation: Extraocular muscle regeneration in zebrafish requires late signals from insulin-like growth factors. Feb. 7, 2018

Funding: This study was supported by the Alliance for Vision Research, a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB), grant R01 EY022633 from the National Eye Institute and an unrestricted grant from RPB to the U-M Department of Ophthalmology and Visual Sciences. This research utilized the Vision Research Core, the Cancer Center Research Core, and the Michigan Diabetes Research Center at the University of Michigan.


More Articles About: Kellogg Eye Center
Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Vision Impairment as a Risk Factor for Dementia
The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
eye glasses blue two yellow dots
Health Lab
Youth value eyesight but face key barriers to getting eyeglasses
Michigan Medicine research shows that a few key barriers stop young people from getting the glasses they need.   
eyes close up green blue
Health Lab
Treating dry age-related macular degeneration: 6 things to know
Answers about the treatment of age-related macular degeneration, otherwise known as dry AMD, from a Michigan Medicine ophthalmologist.
eye drawing
Health Lab
Cataract surgery reimbursements may not be enough for some patients
For complex cataract surgery, Medicare reimbursements are far lower than a simpler form of the surgery.
Dr. Rajesh Rao using his finger to create a pink line of
Michigan Answers
Dr. Rao’s Michigan Answer: Finding new hope for people with vision loss
What do you do when you know there’s a disease that’s as common as all cancers combined that steals a person’s vision? For Rajesh Rao, M.D., you conduct a groundbreaking first-in-human trial, with the goal of using an adult stem cell-based approach to restore vision. 
News Release
$11.5 Million gift fuels innovation in dry age-related macular degeneration research
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in people over 50. An $11.5 million gift to the University of Michigan Health W.K. Kellogg Eye Center aims to change that.